Join companies like...

Abbvie – Abbott – Allergan – Asahi Kasei – Astellas – Braizon Therapeutics – Exopharm – Galen – Holy Stone Healthcare Co. – Ipsen – Medherant – MedinCell – Minoryx Therapeutics – NeurATRIS – Neuronascent – NEUWAY Pharma – NuvOx Pharma – Otsuka – Santen – Stem Pharm – SOUSEIKAI Global Clinical Research Center – Takeda – UCB – Zambon

Live Webinar

Webinar: Neuroscience Event Preview & Virtual Partnering Platform Demo


Tues, 20 October, 2020 11 AM - 12 PM ET / 5 - 6 PM CEST

Watch our webinar live or sign up for the recording to:

  • Get an overview of the event, including a sneak preview into who’s coming and the plenary session
  • Discover the ins and outs of virtual partnering
  • See a walk-through of the One-on-One Partnering platform and its key features
  • Q&A session

Sign up now

Companies profile

Attendees profile

Asset phase

Why participate?

Find potential R&D collaborations or assets available for in-licensing/acquisition

Identify partners with research solutions such as high throughput screening tools, clinical research capacity, or animal models

Secure funding from new investors or find licensing partners for your portfolio

Discover new diagnostics, biomarkers, adjuvants, carrier systems or technologies

Who will attend?

The Neuroscience Virtual Partnering Event will bring these stakeholders together to pursue:

Business development, licencing, and scouting executives from the biopharma industry

Companies focusing on neurology related diagnostics or biological markers

Biotechs focused on neurology and neuroscience

Tech transfer offers

Early stage researchers from academia, incubators, or research foundations

Companies providing research tools, models or services needed for neuroscience R&D